Novo Nordisk (NVO) is down -15.3%, or -$7.28 to $40.15.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NVO:
- Midday Fly By: Trump ups worldwide tariff to 15%, Gilead buying Arcellx
- Novo Nordisk Stock Falls After Disappointing Drug Trial Results, but Is It a Buy Now? BofA Weighs In
- Novo Nordisk falls -14.7%
- Morning Movers: Arcellx skyrockets following pact to be acquired
- Novo Nordisk Advances DKK 15 Billion Share Buyback, Lifts Treasury Stake to 0.5%